nCombination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: A multicenter phase II study of the Greek Cooperative Group for Lung Cancer
- 1 September 1998
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 21 (3), 213-220
- https://doi.org/10.1016/s0169-5002(98)00028-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patientsEuropean Journal Of Cancer, 1996
- Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.Journal of Clinical Oncology, 1996
- Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerCancer, 1995
- A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancerLung Cancer, 1994
- Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991